Navigation Links
Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
Date:10/6/2011

f Therapy 86

5.4.3 Treatment Usage Patterns 87

6 Global WH Disorder Therapeutics Market: Pipeline Analysis 92

6.1 Introduction 92

6.1.1 Research and Development Pipeline – Menopause 94

6.1.2 Research and Development Pipeline – Endometriosis 96

6.1.3 Research and Development Pipeline - Postmenopausal Osteoporosis 98

6.2 Profiles of Key Late-Stage Drugs in the WH disorder Therapeutics Market 101

6.2.1 Aprela (Bazedoxifene/Conjugated Estrogen) 101

6.2.2 Pristiq (Desvenlaxafine, DVS-233) 102

6.2.3 Visanne 103

6.2.4 Elagolix (NBI-56418) 103

6.2.5 Odanacatib (MK-0822) 104

6.2.6 Viviant (Bazedoxifene) 105

7 Global WH Disorder Therapeutics Market: Competitive Landscape 106

7.1 Market Share Analysis: Women's Health 106

7.2 Competitive Profiling 108

7.2.1 Pfizer Inc 108

7.3 Eli Lilly and Company 109

7.4 Merck & Co. 110

7.5 Procter & Gamble Company 112

7.6 Hoffmann-La Roche Ltd. 114

8 Global WH Disorder Therapeutics Market: Strategic Consolidations 117

8.1 Mergers and Acquisitions 117

8.1.1 Overview 117

8.1.2 Ferring Pharmaceuticals Acquires Global Rights to LYSTEDA from Xanodyne Pharmaceuticals in May 2010 121

8.1.3 BioSante Acquires Elestrin Royalty from Azur Pharma in March 2010 121

8.1.4 Teva-KOWA Pharma Acquires Majority Stake in Taisho Pharmaceutical in February 2010 121

8.1.5 Sciele Pharma Acquires Addrenex Pharmaceuticals in November 2009 121

8.1.6 Warner Chilcott Acquires Prescription Drug Business of Procter & Gamble in October 2009 121

8.1.7 BioSante Pharmaceuticals Merges with Cell Genesys in October 2009 122

8.1.8 Hisamitsu Pharmaceutical Completes Acquisition Of Noven Pharmaceuticals in August 2009 122

8.1.9 Pfizer Acquires Wyeth in January 2009 122

8.1.10 Par Pharmaceuticals Acquires Assets Of Calcitonin & A
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Avista Capital Partners Appoints Hakan Bjorklund as Healthcare Operating Executive
2. New Leader for CyttaConnect™ Medical Monitoring eHealth Division
3. FDA Commissioner Outlines Steps to Spur Biomedical Innovation, Improve Health of Americans
4. A New Model of Healthcare is Unveiled, Offering Seniors Control, Independence and Dignity as They Age
5. Unilife Wins Supply Contract with Nations Largest Healthcare Alliance
6. GlaxoSmithKline Donates Scientific Equipment to Advance IDRIs Global Health Mission
7. ECRI Institute Celebrates National Healthcare Resource & Materials Management Week
8. Cardinal Health to Release First-quarter Financial Results on Oct. 27
9. Craneware Supports Forward-Thinking Community Hospital Executives to Strengthen U.S. Community Healthcares Business Performance
10. Awarepoint Corporation Receives Frost & Sullivans 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award
11. Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... 2015  Uroplasty, Inc. (NASDAQ: UPI ), a medical ... products to treat voiding dysfunctions, today reported financial results ... Global revenue for the Company,s Urgent ® ... new quarterly revenue record, as compared to $3.9 million ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18
... , Part ... SPRING, Md., Nov. 19 The U.S. Food and Drug ... the International Internet Week of Action (IIWA), intended to ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , During the effort, the ...
... , FREMONT, Calif., Nov. 19 WaferGen ... developer of state-of-the-art genetic analysis systems, today announced ... thousands of genes using the SmartChip(TM) Real-Time PCR ... Real-Time PCR system, WaferGen will offer universities, pharmaceutical ...
Cached Medicine Technology:FDA Issues 22 Warning Letters to Web Site Operators 2WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 4
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
(Date:1/22/2015)... 22, 2015 Compare-autoinsurance.org has released a new blog ... an auto insurance policy . , Some types of ... should check the newly released blog post to see if their ... dangerously damaged vehicles are some of the cars that cannot be ...
(Date:12/26/2014)... The US represents the largest market for ... GlobalData’s forecast estimates that sales of branded therapies were $2.23 ... the high incidence of the disease, high drug treatment rate, ... China. Increased sales of CRC therapies over the forecast period ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... http://www.nhs.uk ), the,digital ,front door, to the NHS launches ... both the physical and financial cost of smoking in ... interactive calculator,( http://www.nhs.uk/Tools/Pages/Smoking.aspx ) enables users to not only ... much you could save over,one to ten years - ...
... 11 In this 90 minute episode, Dr. Drew,reunites several ... they left treatment. Drew reveals who has relapsed, who has ... is comprised of,recovering addicts and fans of the show, will ... happened over the season., (Photos: ...
... as whole grains cuts risk of cerebral infarction , , ... magnesium-rich foods such as whole grains may reduce male ... flow to the brain is blocked, a new Swedish ... Stockholm analyzed the diets and other health/lifestyle habits and ...
... March 11 Perrigo Company,(Nasdaq: PRGO ; TASE) ... U.S. Food and Drug Administration (FDA) for its Abbreviated ... The product is a topical corticosteroid indicated for the ... for the brand, Olux(R),Foam, 0.05%, were approximately $85 million ...
... 11 Verathon(R) is pleased to,announce a new ... 9400,bladder volume instrument with patent-pending NeuralHarmonics(TM),Technology. Small Child ... noninvasively on children weighing less than 60 pounds ... same instrument used for adult,patients. This enhanced BladderScan(R) ...
... German . , Malignant tumors have usually ... death, or apoptosis. Therefore, tumors are often resistant to ... forcing tumor cells to commit suicide. , This ... of the numerous molecular switches regulating the self-destruction process. ...
Cached Medicine News:Health News:Magnesium May Lower Risk for Some Strokes in Male Smokers 2Health News:Perrigo Company Receives Final Approval on Clobetasol Propionate Foam 2Health News:Perrigo Company Receives Final Approval on Clobetasol Propionate Foam 3Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 3Health News:Paradigm shift: Switch for programmed cell death promotes spread of glioblastoma 2
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: